WASHINGTON, Feb 21 (Reuters) - Medical device maker SenoRx may sell up to 5.5 million shares of common stock in an initial public offering expected to raise at least $60.5 million, according to a filing with the U.S. Securities and Exchange Commission on Wednesday.
